Concurrent chemotherapy, proton therapy improves survival in...
For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton...
Genetically enhanced, cord-blood derived immune cells...
Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt...
Tumor-targeting drug shows potential for treating bone...
The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson...
Recommendation for the further treatment...
Joint Statement from Dr. Joseph M. Herman, Clinical Research Director, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, and Dr. Markus Büchler, Chairman, Department of Surgery, University of Heidelberg
On Saturday, July 8, Dr. Joseph M. Herman of The University of Texas MD Anderson Cancer Center and Dr. Markus W Büchler of University of Heidelberg met with the medical team at the No. 1 Hospital...